Contacting Alzamend

ADDRESS:
Alzamend Neuro, Inc.
3802 Spectrum Blvd., Suite 112C
Tampa, FL 33612

(844) 722-6333 (9am – 5pm PT)






[recaptcha]

LEADERSHIP CONTACTS
FORWARD-LOOKING STATEMENTS

Certain statements within this website including, but not limited to, statements related to anticipated commencement of commercial production, targeted pricing and performance goals, and statements that otherwise relate to future periods are forward-looking statements. These statements involve risks and uncertainties, which are described in more detail in the Company’s Offering Statement on Form 1-A filed with the Securities and Exchange Commission, which identifies important risk factors that could cause actual results to differ from those contained in the forward-looking statements. Forward-looking statements may also be included in future periodic reports filed by Alzamend Neuro. Forward-looking statements are made and based on information available to the Company on the date of this website. Alzamend Neuro assumes no obligation to update the information within this website.

An offering statement regarding this offering has been filed with the sec. The SEC has qualified that offering statement, which only means that the company may make sales of the securities described by the offering statement. It does not mean that the SEC has approved, passed upon the merits or passed upon the accuracy or completeness of the information in the offering statement. You may obtain a copy of the offering circular that is part of that offering statement from www.alzamendrega.com.

  • Alzamend Neuro is a registered mark of Alzamend Neuro Inc.
  • © 2019 by Alzamend Neuro, Inc. All rights reserved.